Caroline Bumb Selected Research

Estrogen Receptors

8/2017	NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.
2/2013	Racial differences in outcomes of triple-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caroline Bumb Research Topics

Disease

4	Breast Neoplasms (Breast Cancer) 10/2017 - 02/2013
2	Neoplasms (Cancer) 09/2013 - 02/2013
1	Triple Negative Breast Neoplasms 02/2013
1	Pathologic Complete Response 02/2013

Drug/Important Bio-Agent (IBA)

2	Estrogen ReceptorsIBA 08/2017 - 02/2013
1	Circulating Tumor DNAIBA 10/2017
1	neratinibIBA 10/2017
1	Anastrozole (Arimidex)FDA LinkGeneric 08/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2017
1	palbociclibIBA 08/2017
1	Cyclin-Dependent Kinase 4IBA 08/2017
1	Goserelin (Zoladex)FDA Link 08/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2013

Therapy/Procedure

1	Transplantation 09/2013
1	Therapeutics 09/2013
1	Adjuvant Chemotherapy 02/2013
1	Neoadjuvant Therapy 02/2013